Investor letter: Thrive's 2022 early-stage $516M fund that invested in OpenAI and SpaceX was worth $3.7B+ as of the end of June, net of fees and other charges

Bloomberg 2026-08-14 Natasha Mascarenhas

Context & Ripple Effects

Thrive had already scaled beyond its earlier fund pair, raising more than $10B for its tenth fund after reporting substantial distributions from its 2021-era capital. Its 2022 early-stage vehicle now provides a marked, net-of-fees result alongside investments in OpenAI and SpaceX.

The firm’s OpenAI exposure has expanded through its 2024 OpenAI round investment and a later $1B OpenAI investment at a $285B valuation. The new fund valuation shows how a small set of frontier-company positions can shape a venture manager’s reported performance.

First-order effects

Thrive can present a more than $3.7B net valuation for its $516M 2022 early-stage fund to limited partners, strengthening the performance record behind its current fundraising and asset base.
OpenAI and SpaceX are named holdings in a fund whose reported value has risen sharply, making those positions central to investor scrutiny of Thrive’s marks and eventual liquidity.

Second-order effects

Thrive’s fundraising pitch gains support from a realized-on-paper example of concentrated early-stage upside, raising the bar for rival venture firms seeking commitments from the same limited-partner pool.
The result reinforces the value of access to scarce frontier-company rounds: Thrive’s later OpenAI investment extends the relationship from an early fund holding into larger-scale capital deployment.

Third-order effects

If large fund outcomes continue to be driven by a handful of private frontier companies, venture returns and fundraising will concentrate further among managers able to secure repeat access to those companies.
That concentration shifts the venture model toward larger, longer-duration platforms that can finance follow-on rounds as well as make early bets, as reflected in Thrive’s $10B-plus tenth fund.

The trend: Frontier-company value appreciation is concentrating venture-fund performance and reinforcing the fundraising advantage of managers with repeat access to major private AI and space companies.

Discussion

@shanumathew93 Shanu Mathew on x
The AI native/PE-roll-up platform idea doing some work, huh “We now have a dedicated team of 35 engineers and operators working alongside the operators inside these businesses. On our accounting platform, we have built custom agents that have achieved 98% accuracy and reduced
@nchirls Nicholas Chirls on x
I tend to talk more shit than most about the big banks in venture - I believe most of them are uninspiring slop factories. Thrive is not that - It's an inspiring example of what great can look like at scale, long-term independent thinking, and a rare form of humble ambition. Mad
@annbordetsky Ann Bordetsky on x
Thrive's letter is legendary worth reading all of it so much to admire here but what Thrive does unbelievably well is combine elite level execution with radical open-mindedness, they're navigating the world not stamping out a cookie cutter venture playbook
@jrogrow John Rotonti Jr on x
So, so good @JoshuaKushner... “It is difficult to overstate the magnitude of the opportunity. It would also be a grave error in our minds to let excitement weaken our investment discipline. In moments of euphoria, investors tend to convince themselves that second- and third-tier
Natasha Mascarenhas Natasha Mascarenhas on linkedin
I obtained Thrive CEO Josh Kushner's recent investor letter, which reveals whole a host of new details — from the latest returns behind …

Chronicles